Volpara Health Risk Pathways
作成者: Volpara Health, Inc.
Complete solution for identifying and managing high-risk patients
- Patient portal to ask the right questions and assess the risk of every patient: Patients can complete digital surveys at home or in the clinic to measure their lifetime and hereditary risk.
- Align risk models & guidelines to help you define the right care plan: Access a set of up-to-date risk models and clinical guidelines to identify and stratify patients on their risk of developing breast cancer.
- Models: Tyrer-Cuzick 6, 7, and 8, Gail, Myriad, Claus, BRCAPRO.
- Clinical guidelines: ACR, USPSTF, NCCN.
- Expand beyond breast: Endometrial, ovarian, colorectal, and pancreatic risk already available. Discuss with our team how we can embed your preferred risk models.
- Nimble interfaces with major genetics labs: Vendor-neutral test request forms reduce paper workflows, help with patient tracking, and allow you to use the lab or labs that best meets your needs. Labs currently enabled: Ambry, Myriad, Natera, Invitae
- Monitor your higher-risk population: A convenient, easy-to-use system tracks patient progress, updates risk profiles, generates communication, and triggers follow-up.
- Empower patients and provides by sending the the right message in the right method: Create educational or medical necessity communications for patients, physicians, and payers to advocate for and better coordinate care.
- Technology that works with your workflow: Proven IT integrations to streamline workflow. Seamless, integrated cancer risk assessment and decision support inside major EHRs, mammography reporting systems, or the cloud.
Volpara Health Technologies makes software to save families from cancer. Healthcare providers use Volpara to better understand cancer risk, empower patients in personal care decisions, and guide recommendations about additional imaging, genetic testing, and other interventions. Our AI-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression, and dose. In an industry facing increasing staffing shortages, our software streamlines operations and provides key performance insights that support continuous quality improvement.
Volpara is the preferred partner of leading healthcare institutions around the world. Our software is used in over 2,000 facilities by more than 5,000 technologists, impacting nearly 16 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware, and genetic laboratories. Volpara holds the most rigorous security certifications and numerous patents and regulatory registrations, including FDA clearance and CE marking.